These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 28427039

  • 1. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E, Harris M, Hughes I, Crock PA, Ambler G, Verge CF, Bergman P, Werther G, Craig ME, Choong CS, Davies PSW, PWS and OZGROW collaboration.
    Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
    [Abstract] [Full Text] [Related]

  • 2. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E, Hughes I, Harris M, Ambler G, Crock P, Verge CF, Craig ME, Bergman P, Werther G, van Driel M, Davies PS, Choong CS.
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [Abstract] [Full Text] [Related]

  • 5. Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study.
    Corripio R, Tubau C, Calvo L, Brun C, Capdevila N, Larramona H, Gabau E.
    J Pediatr Endocrinol Metab; 2019 Aug 27; 32(8):879-884. PubMed ID: 31271556
    [Abstract] [Full Text] [Related]

  • 6. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A, Di Giorgio G, Manco M, Grugni G, Maggioni A.
    Horm Res; 2007 Aug 27; 68(2):83-90. PubMed ID: 17337902
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep 27; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 8. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE, Lindberg A, Heissler J, Wollmann HA, Camacho-Hübner C, Hokken-Koelega AC, KIGS Steering Committee.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1702-1711. PubMed ID: 28323917
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A, Choi JH, Sohn YB, Eom Y, Lee J, Yoo HW, Jin DK.
    Orphanet J Rare Dis; 2019 Sep 11; 14(1):216. PubMed ID: 31511031
    [Abstract] [Full Text] [Related]

  • 10. Benefit of early commencement of growth hormone therapy in children with Prader-Willi syndrome.
    Nyunt O, Harris M, Hughes I, Huynh T, Davies PS, Cotterill AM.
    J Pediatr Endocrinol Metab; 2009 Dec 11; 22(12):1151-8. PubMed ID: 20333875
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U, Christiansen JS, Farholt S, Lämmer C, Ostergaard JR, Schmidt F, Kappelgaard AM, Eiholzer U.
    Horm Metab Res; 2013 Jul 11; 45(7):532-6. PubMed ID: 23632904
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
    Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzén EM.
    Acta Paediatr; 1998 Jan 11; 87(1):28-31. PubMed ID: 9510443
    [Abstract] [Full Text] [Related]

  • 13. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
    Lindgren AC, Ritzén EM.
    Acta Paediatr Suppl; 1999 Dec 11; 88(433):109-11. PubMed ID: 10626558
    [Abstract] [Full Text] [Related]

  • 14. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.
    Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Oct 11; 98(10):4013-22. PubMed ID: 24001750
    [Abstract] [Full Text] [Related]

  • 15. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
    Lin HY, Lin SP, Tsai LP, Chao MC, Chen MR, Chuang CK, Huang CY, Tsai FJ, Chou IC, Chiu PC, Huang CH, Yen JL, Lin JL, Kuo PL.
    J Chin Med Assoc; 2008 Jun 11; 71(6):305-9. PubMed ID: 18567561
    [Abstract] [Full Text] [Related]

  • 16. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct 11; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 17. Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome.
    Magill L, Laemmer C, Woelfle J, Fimmers R, Gohlke B.
    Orphanet J Rare Dis; 2020 Oct 12; 15(1):283. PubMed ID: 33046090
    [Abstract] [Full Text] [Related]

  • 18. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T, Lindberg A, Koltowska-Häggström M, Ranke M.
    Clin Endocrinol (Oxf); 2014 Nov 12; 81(5):721-6. PubMed ID: 24750131
    [Abstract] [Full Text] [Related]

  • 19. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
    Gao Y, Yang LL, Dai YL, Shen Z, Zhou Q, Zou CC.
    Orphanet J Rare Dis; 2023 Feb 07; 18(1):25. PubMed ID: 36750945
    [Abstract] [Full Text] [Related]

  • 20. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U, Meinhardt U, Gallo C, Schlumpf M, Rousson V, l'Allemand D.
    J Pediatr; 2009 Feb 07; 154(2):225-9. PubMed ID: 18822426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.